Novel antibodies reacting with two neighboring gangliosides are induced in rabbits immunized with bovine brain gangliosides

Glycobiology

Volumn 22, Issue 12, 2012, Pages 1768-1774

  Moyano, Ana L ^a   Comín, Romina ^a   Vilcaes, Aldo A ^a   Funes, Samanta C ^a   Roth, Germán A ^a   Irazoqui, Fernando J ^a   Nores, Gustavo A ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

density dependent binding; experimental neuropathy; ganglioside complex; gangliosides

Indexed keywords

GANGLIOSIDE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1B; GANGLIOSIDE GM1;

AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY ISOLATION; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL RABBIT; IMMUNIZATION; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THIN LAYER CHROMATOGRAPHY;

ANIMALS; BRAIN CHEMISTRY; CATTLE; G(M1) GANGLIOSIDE; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; IMMUNOGLOBULIN G; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; RABBITS; RATS;

ANIMALIA; BOVINAE; ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 84868597665     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cws117     Document Type: Article

References (33)

1. Ariga T, Miyatake T, Yu RK. 2001. Recent studies on the roles of antiglycosphingolipids in the pathogenesis of neurological disorders. J Neurosc Res. 65:363-370.
2. Brocca P, Berthault P, Sonnino S. 1998. Conformation of the oligosaccharide chain of GM1 ganglioside in a carbohydrate-enriched surface. Biophys J. 74:309-318.
3. Chen C, Fu Z, Kim JJ, Barbieri JT, Baldwin MR. 2009. Gangliosides as high affinity receptors for tetanus neurotoxin. J Biol Chem. 284:26569-26577.
4. Comín R, Yuki N, Lopez PHH, Nores GA. 2006. High affinity of anti-GM1 antibodies is associated with disease onset in experimental neuropathy. J Neurosci Res. 84:1085-1090.
5. Cygler M, Rose DR, Bundle DR. 1991. Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. Science. 254:442-445.
6. Dam TK, Brewer CF. 2010. Lectins as pattern recognition molecules: The effects of epitope density in innate immunity (Review). Glycobiology. 20:270-279.
7. Dunkley PR, Jarvie PE, Heath JW, Kidd GJ, Rostas JA. 1986. A rapid method for isolation of synaptosomes on Percoll gradients. Brain Res. 372:115-129.
8. Folch-Pi J, Lees M, Sloane Stanley GM. 1957. A simple method for the insolation and purification of total lipids from animal tissues. J Biol Chem. 226:497-509.
9. Gleeson PA. 1994. Glycoconjugates in autoimmunity. Biochim Biophys Acta. 1197:237-255.
10. Hakomori S, Zhang Y. 1997. Glycosphingolipid antigens and cancer therapy. Chem Biol. 4:97-104.
11. Hirabayashi Y, Susuki T, Susuki Y, Taki T, Matsumoto M, Higashi H, Kato S. 1983. A new method for purification of anti-glycosphingolipid antibody. Avian anti-hematoside (NeuGc) antibody. J Biochem. 94:327-330.
12. Kaida K, Morita D, Kanzaki M, Kamakura K, Motoyoshi K, Hirakawa M, Kusunoki S. 2004. Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Ann Neurol. 56:567-571.
13. Kremer DM, López PHH, Mizutamari RK, Bacile EA, Nores GA. 1997. Factors affecting glycolipid recognition by antibodies: Density-dependent binding of anti-GD1a polyclonal IgG from a neurological patient. J Neurosc Res. 47:636-641.
14. Krengel U, Olsson LL, Martínez C, Talavera A, Rojas G, Mier E, Angström J, Moreno E. 2004. Structure and molecular interactions of a unique antitumor antibody specific for N-glycolyl GM3. J Biol Chem. 279:5597-5603.
15. Kusunoki S, Kaida K. 2011. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders (Review). J Neurochem. 116:828-32.
16. Lopez PHH, Irazoqui FJ, Nores GA. 2000. Normal human plasma contains antibodies that specifically block neuropathy-associated human anti-GM1 IgG-antibodies. J Neuroimmunol. 105:179-183.
17. Lopez PHH, Lardone RD, Irazoqui FJ, Villa AM, Di Egidio M, Saizar RD, Sica REP, Nores GA. 2001. Variable patterns of anti-GM1 IgM-antibody population defined by affinity and specificity in patients with motor syndromes. J Neuroimmunol. 119:131-136.
18. Lopez PHH, Villa A, Sica REP, Nores GA. 2002. High affinity as a disease associated factor in anti-GM1 antibodies: Comparative characterization of experimentally produced vs. disease-associated antibodies. J Neuroimmunol. 128:69-76.
19. Maggio B. 2004. Favorable and unfavorable lateral interactions of ceramide, neutral glycosphingolipids and gangliosides in mixed monolayers. Chem Phys Lipids. 132:209-224.
20. Maggio B, Cumar FA, Caputto R. 1978. Interactions of gangliosides with phospholipids and glycosphingolipids in mixed monolayers. Biochem J. 175:1113-1118.
21. Mauri L, Casellato R, Ciampa MG, Uekusa Y, Kato K, Kaida KI, Motoyama M, Kusunoki S, Sonnino S. 2012. Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer of GM1-GD1a. Glycobiology 22:351-360.
22. Mouquet H, Scheid JF, Zoller MJ, Krogsgaard M, Ott RG, Shukair S, Artyomov MN, Pietzsch J, Connors M, Pereyra F et al. 2010. Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature 467:591-595.
23. Moyano AL, Comín R, Lardone RD, Alaniz ME, Irazoqui FJ, Nores GA. 2008. Validation of a rabbit model of neuropathy induced by immunization with gangliosides. J Neurol Sci. 272:110-114.
24. Murase T, Zheng RB, Joe M, Bai Y, Marcus SL, Lowary TL, Ng KK. 2009. Structural insights into antibody recognition of mycobacterial polysaccharides. J Mol Biol. 392:381-392.
25. Nores GA, Dohi T, Taniguchi M, Hakomori S. 1987. Density dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: Requirements for tumor-associated antigen and immunogen. J Immunol. 139:3171-3176.
26. Osinaga E, Bay S, Tello D, Babino A, Pritsch O, Assemat K, Cantacuzene D, Nakada H, Alzari P. 2000. Analysis of the fine specificity of Tn-binding proteins using synthetic glycopeptide epitopes and a biosensor based on surface plasmon resonance spectroscopy. FEBS Lett. 469:24-28.
27. Oyelaran O, Li Q, Farnsworth D, Gildersleeve JC. 2009. Microarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies. J Proteome Res. 8:3529-3538.
28. Prinetti A, Loberto N, Chigorno V, Sonnino S. 2009. Glycosphingolipid behaviour in complex membranes (Review). Biochim Biophys Acta. 1788:184-193.
29. Vilcaes AA, Furlan G, Roth GA. 2009. Inhibition of Ca(2+)-dependent glutamate release from cerebral cortex synaptosomes of rats with experimental autoimmune encephalomyelitis. J Neurochem. 108: 881-890.
30. Vyas NK, Vyas MN, Chervenak MC, Johnson MA, Pinto BM, Bundle DR, Quiocho FA. 2002. Molecular recognition of oligosaccharide epitopes by a monoclonal Fab specific for Shigella flexneri Y lipopolysaccharide: X-ray structures and thermodynamics. Biochemistry. 41: 13575-13586.
31. Williams MA, McCluer RH. 1980. The use of Sep-Pak C18 cartridges during the isolation of gangliosides. J Neurochem. 35:266-269.
32. Yu RK, Ledeen RW. 1972. Gangliosides of human, bovine and rabbit plasma. J Lipid Res. 13:680-687.
33. Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, Ueda S, Kasama T, Ohnishi A, Hayashi S et al. 2001. Animal model of axonal Guillain-Barre syndrome induced by sensitization with GM1 ganglioside. Ann Neurol. 49:712-720.